Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: MarketLine (a Datamonitor Company)
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gimv Nv Sells Stake in Ablynx NV

Thursday, 17 Oct 2013 11:45am EDT 

Gimv Nv announced that the Company and its subsidiary Biotech Fonds Vlaanderen sold their remaining stake in the Belgian biotech company Ablynx NV. This exit has a positive impact of EUR 3.8 million (0.15 EUR per share) on Gimv NV's last published equity value as per 30 June 2013. 

Company Quote

-0.375 -0.86%
2 Jul 2015